跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 152 条关于
“plexiform neurofibroma”
全部
152
临床试验
104
药物
3
机构
0
资讯
45
去年
Selumetinib Demonstrates Efficacy in Adult NF1 Patients with Inoperable Plexiform Neurofibromas
去年
Selumetinib Shows Promise in Treating Adult NF1-Associated Plexiform Neurofibromas
去年
Historical Challenges in NF1-Associated Plexiform Neurofibroma Treatment Drive Development of Targeted Therapies
去年
Neurofibromatosis Type 1 with Plexiform Neurofibromas: Diagnosis, Epidemiology and Clinical Manifestations
去年
Mirdametinib Demonstrates Significant Tumor Reduction and Improved Quality of Life in NF1-Associated Plexiform Neurofibroma
去年
Mirdametinib Shows Deep Responses in NF1-Associated Plexiform Neurofibromas
去年
European Commission Approves First MEK Inhibitor for NF1-Associated Plexiform Neurofibromas in Adults and Children
2年前
FDA Grants Priority Review to Mirdametinib for NF1-Associated Plexiform Neurofibromas
9个月前
Pasithea Therapeutics Secures $60 Million Funding to Advance MEK Inhibitor for Neurofibromatosis Treatment
10个月前
Long-Term Mirdametinib Data Shows Improved Response Rates and Deeper Tumor Shrinkage in NF1-Associated Plexiform Neurofibromas
第 1 页,共 5 页
上一页
下一页